|
“Three Days That Will
Affect The Rest of Your Year!”
|
Leadership Plenary Speakers:
|
|
|
Rick Bayney,
Ph.D.,
Vice President, Decision Analysis and Portfolio Management,
PRD, Johnson & Johnson
|
|
|
Jan-Anders Karlsson, Ph.D. Executive Vice President, Pharma Research, Bayer Healthcare AG
|
| |
|
 |
Christopher A. Lipinski, Ph.D., Adjunct Senior Research Fellow, Pfizer Global R&D
|
| |
|
 |
Ismail Kola, Ph.D.,
Senior Vice President, Basic Research, Site Head for Basic Research, Rahway, Merck Research Laboratories
|
|
| |
|
|
|
Gianni Gromo, M.D.,
Head of Discovery Research Basel, F. Hoffmann-La Roche Ltd
|
| |
|
|
|
Mr. Jan Malek,
PA Consulting
|
| |
|
|
|
Robert R. Ruffolo, Ph.D.,
President, Research & Development, Wyeth Pharmaceuticals, Senior Vice President, Wyeth Corporation
|
| Hear Pharmaceutical Leaders Present on the Following Topics:
|
 |
R&D Strategic Decision Making |
|
Leveraging Technology and Informatics to Improve Productivity |
|
The Future of the Pharmaceutical Industry |
|
Integrating Discovery, Development, Marketing and Licensing |
|
Strategies to Reduce Late Stage Attrition |
|
Impact of Partnering and Alliances on Pharmaceutical Performance |
|
Strategic Perspectives on Clinical Development |
Leadership Presenters
Dr. Jay Anderson, Eli Lilly and Co.
Rick Bayney, Ph.D., Johnson & Johnson
Dr. Matthew Bell, Wyeth Research
Dr. Chris Chamberlain, Roche Products
Dennis Engers, Sanofi-Aventis
Xavier Frapaise, M.D., TAP Pharmaceuticals
Rainer Fuchs, Ph.D., Biogen IDEC
Gianni Gromo, M.D., F. Hoffmann-La Roche Ltd.
Dr. Stephen Hutchins, Merck & Co.
Charles Jaffe, M.D., Ph.D., AstraZeneca
Shama Kajiji, Pfizer, Inc.
Jan-Anders Karlsson, Ph.D., Bayer Healthcare AG
Ismail Kola, Ph.D., Merck Research Laboratories
Michael N. Liebman, Ph.D., Windber Research Institute
Christopher A. Lipinski, Ph.D., Pfizer Global R&D
Jan Malek, PA Consulting Group
Ronald C. Newbold, PhD., MBA, Merck Research Laboratories
Dr. Adrian Otte, Pfizer, Inc.
James Resch, Ph.D., AstraZeneca
Robert R. Ruffolo, Ph.D., Wyeth Pharmaceuticals, Wyeth Corporation
Dr. R. Christopher Seaton, Bayer Pharmaceuticals
James B. Summers, Ph.D., Abbott Laboratories
Dr. Wim Swyzen, Johnson & Johnson
Qualified Attendees Only: Summit attendance is limited to senior executives, directors and managers at pharmaceutical, biopharmaceutical, biotechnology and solutions companies; past Pharmaceutical Strategy Series speakers and delegates; senior faculty at research universities and institutes; government agencies; and sponsoring organizations.
Testimonial from PSS Alumni (Stratefied Pharmaceuticals Participant)
“A Groundbreak Conference That Provides Relevant Knowledge From Key Thought Leaders in This Evolving space”
William C., Director, Strategic Initiatives, MDS Inc.
Call for Sponsors
Showcase your company’s expertise, brand your solutions and develop revenue opportunities with qualified decision-makers by becoming a Sponsor! If you want to discuss sponsoring at this conference, please contact Arnold Wolfson at 781-972-5431,
awolfson@healthtech.com
|
